Uncovering the molecular mechanisms behind immune system activation could help in future gene therapies

January 29, 2014
Pinpointing an immune-response trigger
During bacterial infection (purple discs), or cell transformations such as tumor growth, cells accumulate IPP antigens (light blue circles), which then bind to butyrophilin 3A1 (red). Together, they stimulate the T-cell receptors (TCR) of gamma delta T cells (right). Credit: A*STAR Singapore Immunology Network

The ability to recognize antigens from invading microbes and damaged host cells allows the human body to trigger powerful immune responses. A particular group of white cells, known as gamma delta T cells (γδ T cells), is activated during initial infection in response to the accumulation of an antigen called isopentenyl pyrophosphate (IPP). However, as IPP does not bind directly with γδ T-cell receptors, researchers assumed that another molecule was responsible for presenting IPP to γδ T cells.

Now, Gennaro De Libero and co-workers at the A*STAR Singapore Immunology Network and A*STAR Singapore Bioimaging Consortium—together with scientists from Switzerland, Australia and the United Kingdom—have shown that a protein called butyrophilin 3A1 (BTN3A1) activates human γδ T by binding with IPP. Their discovery could lead to targeted therapies for tumors and other diseases that require a heightened, rapid immune response.

"In our preliminary studies, we found that a γδ T-cell antigen-presenting molecule (APM) was distributed in many tissues and was different from all the other known APMs," explains De Libero. "We exploited a novel strategy to identify the gene encoding the APM."

In initial investigations into human γδ T cells, the team found that their data was complicated by high background readings from other white-cell activity. To minimize this interference, they generated transgenic mice capable of expressing specific human γδ T-cell receptor chains. Through careful screening, the researchers found that only certain human cells were able to present IPP and activate the γδ T cells.

"By pinpointing these cell types, we were able to use the mouse–human hybrid cells to map the human chromosome and find the locus in which the gene encoding the unknown APM was located," explains De Libero. "By applying molecular and cellular techniques, we then identified the molecule as BTN3A1."

Using mass spectroscopy, the researchers were able to visualize the formation of BTN3A1-antigen complexes. IPP antigens bind to a small cleft in BTN3A1 to form a stable complex, which in turn stimulates the γδ T-cell receptors (see image). When BTN3A1 is inhibited, fewer IPP antigens are presented to γδ T cells, weakening the immune response.

The team found that BTN3A1 is widely expressed in the body, particularly in tumor cells where host IPP is prevalent. BTN3A1 could therefore play a vital role in new gene therapies.

"BTN3A1 might be exploited to present stimulatory antigens to human γδ T cells," says De Libero. "This could be used to preferentially kill ."

Explore further: Lipids produced within the thymus give immune cells the initial boost they need to fight off infection

More information: Vavassori, S., Kumar, A., Wan, G. S., Ramanjaneyulu, G. S., Cavallari, M. et al. Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells. Nature Immunology 14, 908–916 (2013). dx.doi.org/10.1038/ni.2665

Related Stories

Novel mechanism discovered in first line of immune defence

September 10, 2013

Scientists from A*STAR's Singapore Immunology Network (SIgN) have discovered a new defense mechanism that the immune system utilises to combat infections. The team's discovery of how a novel protein unexpectedly activates ...

Getting personal with hep B vaccines

December 19, 2013

Therapeutic vaccines that boost antiviral immunity provide an attractive alternative to drug therapy for people who are infected with the hepatitis B virus (HBV). Yet, the large amount of genetic diversity found in circulating ...

Recommended for you

Snapshot turns T cell immunology on its head

October 6, 2015

Challenging a universally accepted, longstanding consensus in the field of immunity requires hard evidence. New research from the Australian Research Council Centre of excellence in advanced Molecular imaging has shown the ...

Four gut bacteria decrease asthma risk in infants

September 30, 2015

New research by scientists at UBC and BC Children's Hospital finds that infants can be protected from getting asthma if they acquire four types of gut bacteria by three months of age. More than 300 families from across Canada ...

Flu infection reveals many paths to immune response

September 28, 2015

A new study of influenza infection in an animal model broadens understanding of how the immune system responds to flu virus, showing that the process is more dynamic than usually described, engaging a broader array of biological ...

Immune cells may help fight against obesity

September 15, 2015

While a healthy lifestyle and "good genes" are known to help prevent obesity, new research published on September 15 in Immunity indicates that certain aspects of the immune system may also play an important role. In the ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.